New clinical trial can make diabetes patients insulin independent

Research which uses pancreatic islet cell implants shows promising results in treating Type 1 Diabetes.

Reports by  World Health Organization (WHO), show that there are now over 422 million people in the world affected by diabetes.

According to Futurism, the clinical trials which involve pancreatic islet cell implants to the omentum (the tissue which covers the organs in the abdomen), can potentially treat diabetes.

The researchers said in the paper, “Islet transplantation can restore euglycemia and eliminate severe hypoglycemia in patients with [T1D].” They further added, “The omentum has a dense vascularized surface for islet implantation, drains into the portal system, and is easily accessible.”

In the clinical trial, the usual insulin dosage of the patients was stopped after the transplant for 17 days. Following this, their glucose level showed improvements.

The lead author, David Baidal said: “The results thus far have shown that the omentum appears to be a viable site for islet implantation using this new platform technique.”

To read the original story, click here.

Share the positive!